On What Basis Did Gamida Cell (GMDA) Stock Drop -21% In Pre-Market Trading On Tuesday?

After delivering an update, Gamida Cell Ltd. (NASDAQ: GMDA) is down on the charts today, down -21.93% to trade at $1.39 at the last check in premarket activity. What update has GMDA given us? In relation to the company’s Biologics License Application (BLA) for omidubicel, the company’s advanced cell therapy candidate for allogeneic hematopoietic stem […]

Fosters Research
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.